Terlipressin Versus Norepinephrine As Infusion in Patients with Septic Shock: a Multicentre, Randomised, Double-Blinded Trial

Zi-Meng Liu,Juan Chen,Qiuye Kou,Qinhan Lin,Xiaobo Huang,Zhanhong Tang,Yan Kang,Ke Li,Lixin Zhou,Qing Song,Tongwen Sun,Ling Zhao,Xue Wang,Xiandi He,Chunting Wang,Benquan Wu,Jiandong Lin,Shiying Yuan,Qin Gu,Kejian Qian,Xianqing Shi,Yongwen Feng,Aihua Lin,Xiaoshun He,Study Group of investigators,Xiang-Dong Guan
DOI: https://doi.org/10.1007/s00134-018-5267-9
IF: 38.9
2018-01-01
Intensive Care Medicine
Abstract:Recent clinical data suggest that terlipressin, a vasopressin analogue, may be more beneficial in septic shock patients than catecholamines. However, terlipressin’s effect on mortality is unknown. We set out to ascertain the efficacy and safety of continuous terlipressin infusion compared with norepinephrine (NE) in patients with septic shock.
What problem does this paper attempt to address?